Notice Regarding the Expected Recognition of a Gain on Sale of Investment Securities (Extraordinary Income) | RAKUS Co.,Ltd. (3923) timely disclosure

Worth reading

34Immaterial

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Improvement

Direction inferred from the company’s description.

Scale

Hundreds of millions of yen

Wording

Avoiding a definitive answer

How definitive the wording is.

Expected recognition of a gain on the sale of investment securities (extraordinary income)

Subject Entity

RAKUS Co.,Ltd. (the filing company)

Target Locations / Products

Listed securities held by the Company

Occurrence1 September 2026 (the date on which the Board of Directors resolved to establish the sale limit)

This disclosure09/01/2026

Cause

To partially sell investment shares held for pure investment purposes.

Amount of Impact on Business Performance

Gain on sale of investment securities: ¥2 billion (expected), recorded as an extraordinary gain

Accounting period in which recognized

Financial statements for the fiscal year ending March 2027

Outlook

The sale is scheduled to take place by the end of October 2026. The gain on the sale of investment securities is scheduled to be recognized as an extraordinary gain in the financial results for the fiscal year ending March 2027.

Planned follow-up disclosure

The Company will disclose the gain on the sale of investment securities promptly once the amount has been finalized.

Event that occurred
Item	Details
Event name	Expected recognition of a gain on the sale of investment securities (extraordinary income)
Date of occurrence	1 September 2026 (the date on which the Board of Directors resolved to establish the sale limit)
Subject Entity	RAKUS Co.,Ltd. (the filing company)
Target Locations / Products	Listed securities held by the Company
Cause	To partially sell investment shares held for pure investment purposes.
Amount of Impact on Business Performance	Gain on sale of investment securities: ¥2 billion (expected), recorded as an extraordinary gain
Accounting period in which recognized	Financial statements for the fiscal year ending March 2027
Outlook	The sale is scheduled to take place by the end of October 2026. The gain on the sale of investment securities is scheduled to be recognized as an extraordinary gain in the financial results for the fiscal year ending March 2027.
Planned follow-up disclosure	The Company will disclose the gain on the sale of investment securities promptly once the amount has been finalized.

Items this document does not state (16)

Date recognized / date notice receivedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the change

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To partially sell investment shares held for pure investment purposes.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.